Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04013191 · ClinicalTrials.gov registry record · Phase 1
A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants
A Phase 1 study, sponsored by UCB Biopharma S.P.R.L..
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT04013191: Completed Phase 1 study, sponsored by UCB Biopharma S.P.R.L..
NCT04013191 is a Phase 1 study that has completed, run by UCB Biopharma S.P.R.L.. The registered enrollment target is 28 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04013191, a Phase 1 study, has completed, sponsored by UCB Biopharma S.P.R.L..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the plasma pharmacokinetic of padsevonil in adult and elderly study participants.
Primary Outcome
Cmax was measured in nanograms per milliliter (ng/mL).
Interventions
- DRUG Padsevonil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-07-09 |
| Est. Completion | 2019-10-03 |
| Phase | Phase 1 |
What the finished NCT04013191 record still lists
NCT04013191 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Padsevonil is the first listed.
NCT04013191 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04013191 about?
NCT04013191 is a clinical study titled "A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study Participants". The purpose of the study is to evaluate the plasma pharmacokinetic of padsevonil in adult and elderly study participants.
What is the current status of trial NCT04013191?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2019-07-09. Estimated completion is 2019-10-03.
What interventions are being tested in trial NCT04013191?
The interventions under investigation include: Padsevonil (DRUG).
Who is sponsoring clinical trial NCT04013191?
This trial is sponsored by UCB Biopharma S.P.R.L., which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04013191's enrollment target sits among peer trials
28 1447th of 2000 higher than 538 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI